MYGN

Myriad Genetics Inc. Common Stock (MYGN)

Stock · NASDAQ · Health Care

$3.16as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$4.55
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances

Myriad Genetics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • MYGN
    Myriad Genetics Inc. Common Stock
    $3.16
    ▼ 0.63%
    Market cap $304.17MP/E
  • TKNO
    Alpha Teknova Inc. Common Stock
    $7.13
    ▼ 2.46%
    Market cap $350.10MP/E
    $1.91$7.84
  • IMDX
    Insight Molecular Diagnostics Inc. Common Stock
    $4.16
    ▼ 3.03%
    Market cap $154.99MP/E
    $2.33$8.51
  • QCLS
    Q/C Technologies Inc. Common Stock
    $2.37
    ▲ 0.00%
    Market cap $21.99MP/E
  • BMRA
    Biomerica Inc. Common Stock
    $2.14
    ▲ 1.67%
    Market cap $4.94MP/E
    $1.45$3.31
  • CDIO
    Cardio Diagnostics Holdings Inc. Common stock
    $1.84
    ▼ 1.60%
    Market cap $4.91MP/E
    $0.97$7.91
  • ACHV
    Achieve Life Sciences Inc. Common Shares
    $8.09
    ▼ 1.16%
    Market cap $672.42MP/E
    $2.62$8.61

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
208.93M
Total value held
$477.28M
Institutional holders
194
Top holders this quarter
  • Unknown125.00M
  • Unknown8.89M
  • Unknown6.67M
  • Unknown5.41M
  • Unknown4.50M
  • Unknown4.42M
  • Unknown3.92M
  • Unknown3.17M
  • Unknown2.37M
  • Unknown2.32M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.